Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorUniversity of Alabama at Birmingham

About this trial

Radiosurgery is the use of a focal high dose of radiation therapy to ablate or kill a tumor. This trial will enroll patients with brain metastases 4 cm or less in greatest diameter and will compare 0mm margin to a 2mm margin for treatment.

Eligibility criteria

Qualifiers

Stated willingness to comply with all study procedures and availability for the duration of the study

Male or female, aged 19 and older

Brain metastases diagnosis not requiring retreatment to the same tumor

For females of reproductive potential should undergo pregnancy testing as per UAB Radiation Oncology standard policies

Disqualifiers

Current use of cytotoxic chemotherapy within 3 days of treatment. There are no restrictions on the use of immunotherapy during treatment. TKIs known to be radiation sensitizers such as BRAF should be held at least 24 hours prior to treatment.

Inability to have MRI imaging

Pregnancy

Treatment with another investigational drug 14 days of enrollment

Trial design

Treatments tested in this trial

  • brain metastases radiosurgery

Treatment groups

180 Participants
are divided into 2 treatment groups